Humana (HUM) Current Deferred Revenue (2009 - 2026)

Humana (HUM) has 18 years of Current Deferred Revenue data on file, last reported at $269.0 million in Q1 2026.

• On a quarterly basis, Current Deferred Revenue rose 1.51% year-over-year to $269.0 million in Q1 2026; TTM through Mar 2026 was $269.0 million, a 1.51% increase from a year earlier, with the FY2025 full-year figure at $356.0 million, up 36.92% from the prior year.
• Current Deferred Revenue for Q1 2026 stood at $269.0 million, down from $356.0 million in the prior quarter.
• Over the last five years, Current Deferred Revenue for HUM reached as high as $7.5 billion in Q3 2023 and fell as low as $195.0 million in Q3 2024.
• Historically, Current Deferred Revenue has averaged $1.9 billion across 5 years, with a median of $286.0 million in 2022.
• Across the five-year window, Current Deferred Revenue soared 2694.7% in 2023 and slumped 97.41% in 2024, its largest moves.
• Year by year, Current Deferred Revenue stood at $286.0 million in 2022, then decreased by 6.99% to $266.0 million in 2023, then dropped by 2.26% to $260.0 million in 2024, then soared by 36.92% to $356.0 million in 2025, then fell by 24.44% to $269.0 million in 2026.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $269.0 million in Q1 2026, $356.0 million in Q4 2025, and $265.0 million in Q3 2025.